Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

920

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Multiple Sclerosis
Interventions
DRUG

Fingolimod 0.5 mg

Patients self-administered fingolimod 0.5 mg capsules orally once daily.

DRUG

Fingolimod 1.25 mg

Patients self-administered fingolimod 1.25 mg capsules orally once daily.

Trial Locations (103)

3065

Novartis Investigative Site, Fitzroy

Unknown

Novartis Investigative Site, Chatswood

Austin Health, Department of Neurology, Heidelberg

Novartis Investigative Site, North Gosford

Novartis Investigative Site, Woodville

Novartis Investigative Site, Bruges

Novartis Investigative Site, Brussels

Novartis Investigative Site, Charleroi

Novartis Investigative Site, Leuven

Novartis Investigative Site, Overpelt

Novartis Investigative Site, Sijsele - Damme

Novartis Investigative Site, Sint-Truiden

Novartis Investigative Site, Halifax

Novartis Investigative Site, Kingston

Novartis Investigative Site, London

Novartis Investigative Site, Montreal

Novartis Investigative Site, Nepean

Novartis Investigative Site, Regina

Novartis Investigative Site, Toronto

Novartis Investigative Site, Vancouver

Novartis Investigative Site, Brno

Novartis Investigative Site, Olomouc

Novartis Investigative Site, Ostrava-Poruba

Novartis Investigative Site, Pardubice

Novartis Investigative Site, Plzen - Lochotin

Novartis Investigative Site, Prague

Novartis Investigative Site, Rychnov nad Kněžnou

Novartis Investigative Site, Teplice

Novartis Investigative Site, Talinn

Novartis Investigative Site, Helsinki

Novartis Investigative Site, Tampere

Novartis Investigative Site, Turku

Novartis Investigative Site, Clermont-Ferrand

Novartis Investigative Site, Dijon

Novartis Investigative Site, Lille

Novartis Investigative Site, Marseille

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Nantes

Novartis Investigative Site, Paris

Novartis Investigative Site, Rennes

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Berlin

Novartis Investigative Site, Düsseldorf

Novartis Investigative Site, Giessen

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Magdeburg

Novartis Investigative Site, München

Novartis Investigative Site, Münster

Novartis Investigative Site, Regensburg

Novartis Investigative Site, Stuttgart

Novartis Investigative Site, Tübingen

Novartis Investigative Site, Athens

Novartis Investigative Site, Budapest

Novartis Investigative Site, Miskolc

Novartis Investigative Site, Székesfehérvár

Novartis Investigative Site, Dublin

Novaratis Investigative Site, Ashkelon

Novartis Investigative Site, Haifa

Novartis Investigative Site, Ramat Gan

Novartis Investigative Site, Safed

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Nieuwegein

Novartis Investigative Site, Nijmegen

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Sittard

Novartis Investigative Site, Tilburg

Novartis Investigative Site, Bialystok

Novartis Investigative Site, Gdansk

Novartis Investigative Site, Katowice

Novartis Investigative Site, Lodz

Novartis Investigative Site, Poznan

Novartis Investigative Site, Warsaw

Novartis Investigative Site, Bucharest

Novartis Investigative Site, Craiova

Novartis Investigative Site, Lasi

Novartis Investigative Site, Tg. Mures

Novartis Investigative Site, Kazan'

Novartis Investigative Site, Moscow

Novartis Investigative Site, Saint Petersburg

Novartis Investigational Site, Bratislava

Novartis Investigative Site, Martin

Novartis Investigational Site, Žilina

Novartis Investigational Site, Cape Town

Novartis Investigational Site, Rosebank

Novartis Investigational Site, Umhlanga

Novartis Investigational Site, Gothenburg

Novartis Investigational Site, Stockholm

Novartis Investigative Site, Lausanne

Novartis Investigative Site, Zurich

Novartis Investigational Site, Ankara

Novartis Investigational Site, Bursa

Novartis Investigational Site, Cerrahpasa/Istanbul

Novartis Investigational Site, Gaziantep

Novartis Investigational Site, Istanbul

Novartis Investigational Site, Izmir

Novartis Investigational Site, Mersin

Novartis Investigational Site, Yenisehir/Izmir

Novartis Investigative Site, Bristol

Novartis Investigative Site, London

Novartis Investigative Site, Newcastle upon Tyne

Novartis Investigative Site, Nottingham

Novartis Investigative Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY